Based on the Draegerwerk VZO O.N. stock forecast from 0 analysts, the average analyst target price for Draegerwerk VZO O.N. is not available over the next 12 months. Draegerwerk VZO O.N.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Draegerwerk VZO O.N. is Bullish , which is based on 8 positive signals and 1 negative signals. At the last closing, Draegerwerk VZO O.N.’s stock price was EUR 49.05. Draegerwerk VZO O.N.’s stock price has changed by +0.00% over the past week, -0.30% over the past month and -0.20% over the last year.
No recent analyst target price found for Draegerwerk VZO O.N.
No recent average analyst rating found for Draegerwerk VZO O.N.
Company Overview Draegerwerk VZO O.N.
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, hospitable consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh. Address: Moislinger Allee 53-55, Lübeck, Germany, 23558 Read Less
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine....Read More
Frequently Asked Questions About Draegerwerk VZO O.N. (DRW3:XETRA) Stock
Stock Target Advisor's fundamental analysis for Draegerwerk VZO O.N.'s stock is Bullish .
DRW3:XETRA stock's dividend yield is 3.58%.
Our analysis grades DRW3:XETRA stock's dividend yield at C. This means that DRW3:XETRA stock's dividend yield is above 75% of the stocks in the Medical Devices sector in the XETRA exchange.
Based on this DRW3:XETRA may be a average dividend stock for its sector.
Unfortunately we do not have enough data on DRW3:XETRA's stock to indicate what its average analyst target is.
DRW3:XETRA stock's Price/Earning ratio is 8.39.
Our analysis grades DRW3:XETRA stock's Price / Earning ratio at B+. This means that DRW3:XETRA stock's Price/Earning ratio is above 11% of the stocks in the Medical Devices sector in the XETRA exchange.
Based on this DRW3:XETRA may be undervalued for its sector.
The last closing price of DRW3:XETRA's stock was EUR 49.05.
The most recent market capitalization for DRW3:XETRA is EUR 0.86B.
Unfortunately we do not have enough analyst data on DRW3:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Draegerwerk VZO O.N.'s stock.
As per our most recent records Draegerwerk VZO O.N. has 15,171 Employees.
Draegerwerk VZO O.N.'s registered address is Moislinger Allee 53-55, Lübeck, Germany, 23558.
You can get more information about it from Draegerwerk VZO O.N.'s website at https://www.draeger.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DRW3:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
